BridgeBio Pharma Inc (BBIO)
Healthcare
Biotechnology
80.00 $
-0.2%
vs. previous close
Closing price · As of: 3. Aug 2026
BridgeBio Pharma Inc (BBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -197 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -113 | -145 | -125 | -220 | 75 | -181 | -195 | -199 | -81 | -110 | -56 | -197 | -444 | |
| 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.5 | 1.4 | 1.3 | 1.3 | 1.4 | 1.5 | 1.8 | 6.0 | |
| 27 | 23 | 37 | 17 | 21 | 27 | 30 | 26 | 37 | 35 | 35 | 33 | 140 | |
| 29 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 14 | 1.3 | 22 | -225 | 246 | -2.1 | 13 | -116 | 19 | -3.9 | 50 | -125 | -60 | |
| 0.4 | 0.4 | 0.4 | 1.5 | 2.4 | 1.7 | 3.2 | 1.6 | 5.1 | 0.5 | 4.5 | 0.1 | 10 | |
| 4.1 | 38 | -0.1 | 23 | 3.0 | 38 | -3.2 | -1.6 | -13 | 4.5 | -14 | -43 | -65 | |
| -1.2 | -2.6 | -2.6 | -2.9 | -1.7 | -1.4 | -1.4 | -50 | -2.0 | 3.8 | -5.5 | -83 | -86 | |
| – | – | – | – | – | 0.0 | 500 | 116 | 300 | -300 | 0.0 | 633 | 633 | |
| -1.2 | 307 | -4.5 | 280 | -5.7 | 0.7 | 474 | 60 | 302 | -0.9 | -2.8 | 550 | 848 | |
| -110 | 199 | -129 | 83 | 72 | -142 | 275 | -141 | 208 | -106 | -72 | 310 | 340 | |
| -114 | -146 | -125 | -221 | 72 | -182 | -199 | -201 | -86 | -110 | -61 | -197 | -454 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.